Kozak & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Kozak & Associates’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.57K	Hold	5	–	–	﹤0.01%	348
2026 Q1	$2.57K	Hold	5	–	–	﹤0.01%	357
2025 Q4	$3.09K	Hold	5	–	–	﹤0.01%	346
2025 Q3	$2.84K	Buy	+5	New	+$2.33K	﹤0.01%	362
2025 Q2	–	Sell	-8	Closed	-$3.6K	–	492
2025 Q1	$3.6K	Hold	8	–	–	﹤0.01%	311
2024 Q4	$4.26K	Buy	+8	New	+$4.4K	﹤0.01%	305
2024 Q3	–	Hold	0	–	–	–	396
2024 Q2	–	Sell	-6	Closed	-$3.44K	–	385
2024 Q1	$3.59K	Hold	6	–	–	﹤0.01%	295
2023 Q4	$3.25K	Hold	6	–	–	﹤0.01%	292
2023 Q3	$2.99K	Buy	+6	New	+$3.2K	﹤0.01%	312
2023 Q2	–	Sell	-1,049	Closed	-$605K	–	364
2023 Q1	$605K	Hold	1,049	–	–	0.27%	35
2022 Q4	$578K	Hold	1,049	–	–	0.29%	31
2022 Q3	$525K	Hold	1,049	–	–	0.33%	27
2022 Q2	$570K	Hold	1,049	–	–	0.38%	27
2022 Q1	$565K	Hold	1,049	–	–	0.36%	31
2021 Q4	$565K	Hold	1,049	–	–	0.36%	31
2021 Q3	$663K	Buy	+1,049	New	+$576K	0.39%	29
2020 Q4	$521K	Buy	+1,057	New	+$496K	0.4%	28

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Kozak & Associates's TMO Position: Q2 2026 in Review

Kozak & Associates held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 5 shares worth $2.57K. The position accounts for ﹤0.01% of the portfolio, ranked #348.

Kozak & Associates first reported a position in TMO in Q4 2020 and has held it in 17 quarters since. The position peaked at $663K in Q3 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Kozak & Associates held 5 shares of Thermo Fisher Scientific worth $2.57K as of Q2 2026.
Kozak & Associates left its Thermo Fisher Scientific share count unchanged in Q2 2026.
Thermo Fisher Scientific made up ﹤0.01% of Kozak & Associates's portfolio in Q2 2026, its #348 holding.
Kozak & Associates first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 17 quarters since.
Kozak & Associates's Thermo Fisher Scientific position peaked at $663K in Q3 2021.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.